TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, today announced that Parent Project Muscular Dystrophy (PPMD) will ...

If you haven’t done so already, we encourage you to determine your short- and long-term career goals to identify your postdoc training needs. Creating an IDP is a great way to do this, and when you’re ...

Woodside’s top executive is very bullish about a second development phase on its flagship Sangomar deepwater project offshore Senegal, which is could involve a potential 30-well subsea system.

SEVEN FIELDS, Pa. — The next and final phase of the Route 228 Expansion Project in Butler County is set to begin. “By improving this whole corridor, it should make traffic much safer,” said Tina Gibbs ...

MACON, Ga. — A massive interstate project is coming to an end soon. This week, The Georgia Department of Transportation announced the I-16/I-75 Improvement Project will start its sixth and final phase ...

— This Phase 2 study will evaluate the safety, tolerability and systemic/mucosal immunogenicity of CastleVax’s next generation COVID-19 vaccine compared to an approved mRNA vaccine comparator — ...

Updates to Druid Lake and Druid Hill Park are back on track, as plans for an update to Baltimore’s historic park promise boathouses, event spaces and more neighborhood connectivity by 2029. A ...

KUALA LUMPUR, Oct 22 (Reuters) - The development of a 2,000-megawatt offshore wind energy project linking Vietnam, Malaysia, and Singapore is expected to complete its first phase by 2034, Malaysia's ...

WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for ...

TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks' proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform ...